Thiogenesis Therapeutics, Corp.

Biotechnology • Healthcare • Toronto, ON, United States • TTIPF (OQX)

Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.

Stock Performance (90 Days)

Data through Dec 25, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Rare mitochondrial diseases get spotlight in new drug trial update - Stock Titan

Stock Titan • Jan 5

Thiogenesis Therapeutics Expands on Plans for Phase 3 Pivotal Trial of TTI-0102 in Nephropathic Cystinosis - TMX Newsfile

TMX Newsfile • Nov 24

Is Thiogenesis Therapeutics (CVE:TTI) In A Good Position To Invest In Growth? - simplywall.st

simplywall.st • Jan 1

Thiogenesis Therapeutics, Corp. to Present at the Life Sciences Virtual Investor Forum December 11th - GlobeNewswire

GlobeNewswire • Dec 9

Check out 's stock price (TTIPF) in real time - CNBC

CNBC • Nov 30

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Thiogenesis Therapeutics, Corp. had layoffs?

No layoff events have been recorded for Thiogenesis Therapeutics, Corp. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Thiogenesis Therapeutics, Corp. in?

Thiogenesis Therapeutics, Corp. operates in the Biotechnology industry, within the Healthcare sector.

Is Thiogenesis Therapeutics, Corp. a publicly traded company?

Yes, Thiogenesis Therapeutics, Corp. is publicly traded under the ticker symbol TTIPF on the OQX. The company has a market capitalization of approximately $0.03 billion.

Where is Thiogenesis Therapeutics, Corp. headquartered?

Thiogenesis Therapeutics, Corp. is headquartered in Toronto, ON, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.